| abstract |
There is provided a vaccine for controlling Clostridium perfringens in an imals, and particularly necrotic enteritis in poultry. The vaccine may compr ise a C. perfringens antigenic polypeptide or variant thereof, a nucleic aci d encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or vari ant thereof. |